Anti-Tissue Transglutaminase Antibodies in Patients with Abnormal Liver Tests: Is It Always Coeliac Disease?
- 1 November 2005
- journal article
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 100 (11) , 2472-2477
Abstract
Coeliac disease (CD) is found in 5-10% of patients with chronically abnormal liver tests and no obvious cause of liver disease. In this population the efficacy of screening for CD by anti-tissue transglutaminase (anti-tTG) may be impaired by the high rate of positive anti-tTG found in chronic liver disease. To evaluate the prevalence of coeliac disease and the role of anti-tTG in patients with non-viral, non-autoimmune chronic and no obvious cause of liver damage. Out of 2,512 consecutive patients with abnormal liver tests, 168 (118 men, 50 women; mean age 40.7 +/- 12.6 years) were defined, on the basis of clinical data and liver biopsy, as NAFLD or cryptogenic chronic hepatitis. All were tested by recombinant IgA and IgG anti-tissue transglutaminase. Patients with a positive serology underwent endoscopy with duodenal biopsies. NAFLD was diagnosed in 121 patients, in 6 associated with cirrhosis, while 47 patients were considered as cryptogenic hepatitis in the absence of steatosis. Anti-tTG were positive in 20/168 patients (3 IgA alone; 11 IgG alone; 6 both IgA and IgG). Coeliac disease was found at endoscopy and confirmed by histopathology only in the 6 patients (3.6%) with both IgA and IgG anti-tTG positivity. Four of the patients with CD had NAFLD (3.3%), in 2 of them associated with cirrhosis; while 2 of those with cryptogenic hepatitis (4.2%) had CD. The prevalence of CD in patients with chronically abnormal liver tests of unexplained etiology is 4%, with no relation with the degree of liver steatosis. Screening should be done by testing for IgA and IgG antibodies and then evaluating by endoscopy and biopsy only patients positive for both.Keywords
This publication has 48 references indexed in Scilit:
- Searching for coeliac disease in patients with non-alcoholic fatty liver diseaseDigestive and Liver Disease, 2004
- Is immunoglobulin A anti-tissue transglutaminase antibody a reliable serological marker of coeliac disease?European Journal of Gastroenterology & Hepatology, 2004
- Transglutaminase 2 in celiac disease: Minireview articleAmino Acids, 2004
- High Rate of Positive Anti-Tissue Transglutaminase Antibodies in Chronic Liver DiseaseScandinavian Journal of Gastroenterology, 2003
- Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver diseaseGut, 2001
- Presence of anti-‘tissue’ transglutaminase antibodies in inflammatory intestinal diseases: an apoptosis-associated event?Cell Death & Differentiation, 2001
- Sensitivity of Antiendomysium and Antigliadin Antibodies in Untreated Celiac Disease: Disappointing in Clinical PracticeAmerican Journal of Gastroenterology, 1999
- Prevalence of hypertransaminasemia in adult celiac patients and effect of gluten-free diet*1Hepatology, 1995
- Classification of chronic hepatitis: Diagnosis, grading and stagingHepatology, 1994
- Unsuspected Coeliac Disease in Chronic ‘Cryptogenic’ Liver DiseaseScandinavian Journal of Gastroenterology, 1994